sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Alzheimer's Therapeutics Market By Molecule Type (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E Pharmacies), By Region (North America, Europe, Asia Pacific, and Rest of the World) - Global Forecast up to 2025

Alzheimer's Therapeutics Market By Molecule Type (Cholinesterase Inhibitors, NMDA Receptor...

Home / Categories / Healthcare
Alzheimer's Therapeutics Market By Molecule Type (Cholinesterase Inhibitors, NMDA Receptor Antagonists, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and E Pharmacies), By Region (North America, Europe, Asia Pacific, and Rest of the World) - Global Forecast up to 2025
Alzheimer's Therapeutics Market By Molecule...
Report Code
RO1/122/1113

Publish Date
02/May/2024

Pages
75
PRICE
$ 2750/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 3500/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 4500/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
Tables

TABLE 1 ALZHEIMER'S THERAPEUTICS MARKET REVENUE, BY PRODUCT, 2018-2025 ($MILLION)
TABLE 2 ALZHEIMER'S THERAPEUTICS MARKET REVENUE, BY TYPE, 2018-2025 ($MILLION)
TABLE 3 ALZHEIMER'S THERAPEUTICS MARKET REVENUE, BY GEOGRAPHY, 2018-2025 ($MILLION)
TABLE 4 BUSINESS SUMMARY: NOVARTIS AG
TABLE 5 BUSINESS SUMMARY: EISAI CO. LTD
TABLE 6 BUSINESS SUMMARY: PFIZER INC
TABLE 7 BUSINESS SUMMARY: ELI LILLY & COMPANY
TABLE 8 BUSINESS SUMMARY: JOHNSON & JOHNSON
TABLE 9 BUSINESS SUMMARY: DAIICHI SANKYO COMPANY LTD
TABLE 10 BUSINESS SUMMARY: F. HOFFMANN-LA ROCHE
TABLE 11 BUSINESS SUMMARY: H. LUNDBECK A/S
TABLE 12 BUSINESS SUMMARY: TAURX THERAPEUTICS LTD

LIST OF FIGURE
Charts

CHART 1 GLOBAL PHARMACEUTICAL R&D SPENDING (2010–2016)
CHART 2 ESTIMATED R&D INVESTMENT BY TOP 10 COMPANIES ($BN)
CHART 3 RESEARCH METHODOLOGY OF GLOBAL ALZHEIMER’S THERAPEUTICS MARKET
CHART 4 GLOBAL ALZHEIMER’S THERAPEUTICS MARKET REVENUE, 2018–2025 ($MILLION)
CHART 5 GLOBAL ALZHEIMER’S THERAPEUTICS MARKET SEGMENTATION
CHART 6 PORTERS 5 FORCES ON GLOBAL ALZHEIMER’S THERAPEUTICS MARKET
CHART 7 PEST ANALYSIS OF GLOBAL ALZHEIMER’S THERAPEUTICS MARKET
CHART 8 MARKET DYNAMICS – DRIVERS, RESTRAINTS & OPPORTUNITIES
CHART 9 DRO - IMPACT ANALYSIS OF GLOBAL ALZHEIMER’S THERAPEUTICS MARKET
CHART 10 KEY STAKEHOLDERS OF GLOBAL ALZHEIMER’S THERAPEUTICS MARKET
CHART 11 GLOBAL ALZHEIMER’S THERAPEUTICS MARKET REVENUE, BY PRODUCT, 2018 ($MILLION)
CHART 12 CHOLINESTERASE INHIBITORS MARKET REVENUE, 2018–2025 ($MILLION)
CHART 13 NMDA RECEPTOR ANTAGONISTS MARKET REVENUE, 2018–2025 ($MILLION)
CHART 14 OTHERS MARKET REVENUE, 2018–2025 ($MILLION)
CHART 15 GLOBAL ALZHEIMER’S THERAPEUTICS MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2018–2025 ($MILLION)
CHART 16 HOSPITAL PHARMACIES MARKET REVENUE, 2018–2025 ($MILLION)
CHART 17 RETAIL PHARMACIES MARKET REVENUE, 2018–2025 ($MILLION)
CHART 18 E PHARMACIES MARKET REVENUE, 2018–2025 ($MILLION)
CHART 19 GLOBAL ALZHEIMER’S THERAPEUTICS MARKET BY REGIONAL SEGMENTATION, 2018 (%)
CHART 20 GLOBAL ALZHEIMER’S THERAPEUTICS MARKET BY REGIONAL SEGMENTATION, 2025 (%)
CHART 21 ALZHEIMER’S THERAPEUTICS MARKET REVENUE IN NORTH AMERICA, 2018–2025 ($MILLION)
CHART 22 ALZHEIMER’S THERAPEUTICS MARKET REVENUE IN EUROPE, 2018–2025 ($MILLION)
CHART 23 ALZHEIMER’S THERAPEUTICS MARKET REVENUE IN ASIA PACIFIC, 2018–2025 ($MILLION)
CHART 24 ALZHEIMER’S THERAPEUTICS MARKET REVENUE IN REST OF THE WORLD, 2018–2025 ($MILLION)

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com